VRPX
Virpax Pharmaceuticals Inc

6,213
Mkt Cap
$26,100.00
Volume
505.00
52W High
$26.25
52W Low
$0.01
PE Ratio
0.00
VRPX Fundamentals
Price
$0.021
Prev Close
$0.021
Open
$0.021
50D MA
$0.0165
Beta
1.55
Avg. Volume
2,442.86
EPS (Annual)
-$70.91
P/B
-0.01
Rev/Employee
$0.00
Loading...
Loading...
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
2

Frequently Asked Questions

What is Market Cap of Virpax Pharmaceuticals Inc?
What is the 52-week high for Virpax Pharmaceuticals Inc?
What is the 52-week low for Virpax Pharmaceuticals Inc?
What is Virpax Pharmaceuticals Inc stock price today?
What was Virpax Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Virpax Pharmaceuticals Inc?
What is the Price-to-Book ratio of Virpax Pharmaceuticals Inc?
What is the 50-day moving average of Virpax Pharmaceuticals Inc?
How many employess does Virpax Pharmaceuticals Inc has?

Latest VRPX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.